Watson Pharmaceuticals, Inc. (WPI) Tops Q4 EPS by 1c; Guides FY12 EPS
Tweet
Share
E-mailGet Alerts WPI Hot Sheet
Price: $85.73 --0%
Financial Fact:
Other income (expense): -2.1M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Other income (expense): -2.1M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Watson Pharmaceuticals, Inc. (NYSE: WPI) reported Q4 EPS of $1.77, $0.01 better than the analyst estimate of $1.76. Revenue for the quarter came in at $1.55 billion versus the consensus estimate of $1.54 billion.
Watson Pharmaceuticals, Inc. sees FY2012 EPS of $5.50-$5.80, versus the consensus of $5.60.
For earnings history and earnings-related data on Watson Pharmaceuticals, Inc. (WPI) click here.
Watson Pharmaceuticals, Inc. sees FY2012 EPS of $5.50-$5.80, versus the consensus of $5.60.
For earnings history and earnings-related data on Watson Pharmaceuticals, Inc. (WPI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- CoStar Group acquires Zonda for $800M, adding new home data
- BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
